Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2.
Özbay Kurt FG, Lepper A, Gerhards C, Roemer M, Lasser S, Arkhypov I, Bitsch R, Bugert P, Altevogt P, Gouttefangeas C, Neumaier M, Utikal J, Umansky V. Özbay Kurt FG, et al. Among authors: gouttefangeas c. Front Immunol. 2022 Oct 12;13:1012526. doi: 10.3389/fimmu.2022.1012526. eCollection 2022. Front Immunol. 2022. PMID: 36311732 Free PMC article.
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
Nelde A, Bilich T, Heitmann JS, Maringer Y, Salih HR, Roerden M, Lübke M, Bauer J, Rieth J, Wacker M, Peter A, Hörber S, Traenkle B, Kaiser PD, Rothbauer U, Becker M, Junker D, Krause G, Strengert M, Schneiderhan-Marra N, Templin MF, Joos TO, Kowalewski DJ, Stos-Zweifel V, Fehr M, Rabsteyn A, Mirakaj V, Karbach J, Jäger E, Graf M, Gruber LC, Rachfalski D, Preuß B, Hagelstein I, Märklin M, Bakchoul T, Gouttefangeas C, Kohlbacher O, Klein R, Stevanović S, Rammensee HG, Walz JS. Nelde A, et al. Among authors: gouttefangeas c. Nat Immunol. 2021 Jan;22(1):74-85. doi: 10.1038/s41590-020-00808-x. Epub 2020 Sep 30. Nat Immunol. 2021. PMID: 32999467
Integrin Activation Enables Sensitive Detection of Functional CD4+ and CD8+ T Cells: Application to Characterize SARS-CoV-2 Immunity.
Schöllhorn A, Schuhmacher J, Besedovsky L, Fendel R, Jensen ATR, Stevanović S, Lange T, Rammensee HG, Born J, Gouttefangeas C, Dimitrov S. Schöllhorn A, et al. Among authors: gouttefangeas c. Front Immunol. 2021 Mar 29;12:626308. doi: 10.3389/fimmu.2021.626308. eCollection 2021. Front Immunol. 2021. PMID: 33854501 Free PMC article.
CD8+ T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors.
Dittmann J, Keller-Matschke K, Weinschenk T, Kratt T, Heck T, Becker HD, Stevanović S, Rammensee HG, Gouttefangeas C. Dittmann J, et al. Among authors: gouttefangeas c. Cancer Immunol Immunother. 2005 Aug;54(8):750-8. doi: 10.1007/s00262-004-0640-7. Epub 2004 Dec 22. Cancer Immunol Immunother. 2005. PMID: 15614528 Free PMC article.
A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer.
Löffler MW, Nussbaum B, Jäger G, Jurmeister PS, Budczies J, Pereira PL, Clasen S, Kowalewski DJ, Mühlenbruch L, Königsrainer I, Beckert S, Ladurner R, Wagner S, Bullinger F, Gross TH, Schroeder C, Sipos B, Königsrainer A, Stevanović S, Denkert C, Rammensee HG, Gouttefangeas C, Haen SP. Löffler MW, et al. Among authors: gouttefangeas c. Front Immunol. 2019 Nov 19;10:2526. doi: 10.3389/fimmu.2019.02526. eCollection 2019. Front Immunol. 2019. PMID: 31803175 Free PMC article. Clinical Trial.
Single-Domain Antibodies for Targeting, Detection, and In Vivo Imaging of Human CD4+ Cells.
Traenkle B, Kaiser PD, Pezzana S, Richardson J, Gramlich M, Wagner TR, Seyfried D, Weldle M, Holz S, Parfyonova Y, Nueske S, Scholz AM, Zeck A, Jakobi M, Schneiderhan-Marra N, Schaller M, Maurer A, Gouttefangeas C, Kneilling M, Pichler BJ, Sonanini D, Rothbauer U. Traenkle B, et al. Among authors: gouttefangeas c. Front Immunol. 2021 Dec 9;12:799910. doi: 10.3389/fimmu.2021.799910. eCollection 2021. Front Immunol. 2021. PMID: 34956237 Free PMC article.
113 results